ProUroCare Medical Inc. (ProUroCare) is engaged in the business of developing for market innovative products for the detection and characterization of male urological prostate disease. The primary focus of the Company is the prostate imaging device, known as the ProUroScan System, which is designed to produce an image of the prostate as an adjunctive aid in visualizing and documenting abnormalities of the prostate that have been detected by digital rectal examination. In addition to the real time visual image, the results are stored electronically as a digital record. In April 2012, the ProUroScan System received initial clearance for marketing in the United States by the Food and Drug Administration (FDA).
Medicine Medical Specialties RTT Clinical Medicine Prostate Cancer Food And Drug Administration Histopathology Prostate